A study to evaluate the potential contribution of medication use to falls in elderly patients presenting to an acute hospital by Richardson, M. et al.
UCC Library and UCC researchers have made this item openly available.
Please let us know how this has helped you. Thanks!
Title A study to evaluate the potential contribution of medication use to falls
in elderly patients presenting to an acute hospital
Author(s) Richardson, M.; O'Dwyer, C.; Gaskin, J.; Conyard, E.; Murphy, Kevin
D.
Publication date 2019
Original citation Richardson, M., O' Dwyer, C., Gaskin, J., Conyard, E. and Murphy, K.
(2019) ‘A study to evaluate the potential contribution of medication use
to falls in elderly patients presenting to an acute hospital’ [Poster
Presentation], Hospital Pharmacists Association of Ireland Annual
Conference 2019, Dublin, Ireland, 5-7 April.
Type of publication Conference item
Link to publisher's
version
https://www.hpai.ie/event-3271929
Access to the full text of the published version may require a
subscription.
Rights © 2019, the Authors. All rights reserved.
Item downloaded
from
http://hdl.handle.net/10468/7831
Downloaded on 2019-12-02T15:03:34Z
REFERENCES:
1.Browne C, Kingston C, Keane C. Implementation of a falls prevention focused medication review by a pharmacist in an acute hospital. Irish journal of medical science. 2013;182:S240. 2. de Jong MR, Van der Elst M, Hartholt KA. Drug-related falls in older patients: implicated drugs, 
consequences, and possible prevention strategies. Therapeutic Advances in Drug Safety. 2013;4(4):147-54. 3. HSE. Strategy to Prevent Falls and Fractures  in Ireland’s Ageing Population. 2008. 4.ICGP. Strategy to Prevent Falls and Fractures in Ireland’s Ageing Population. 2008. 5.NICE. 
Falls in older people: assessing risk and prevention Clinical guideline [CG161]. 2013. 6.O’Hanlon N. Briefing Document on  Medication use and Falls 2013. 7.San-José A, Agustí A, Vidal X, Formiga F, Gómez-Hernández M, García J, et al. Inappropriate prescribing to the oldest old patients 
admitted to hospital: prevalence, most frequently used medicines, and associated factors. BMC geriatrics. 2015;15:42. 8.Thorell K, Ranstad K, Midlöv P, Borgquist L, Halling A. Is use of fall risk-increasing drugs in an elderly population associated with an increased risk of hip fracture, after 
adjustment for multimorbidity level: a cohort study. BMC Geriatrics. 2014;14(1):131. 9.Twigg MJ, Wright D, Barton GR, Thornley T, Kerr C. The four or more medicines (FOMM) support service: results from an evaluation of a new community pharmacy service aimed at over-65s. 
International Journal of Pharmacy Practice. 2015:407-14. 10.WHO. WHO Global report on falls Prevention in older Age. 2007.11.Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Archives of Internal Medicine. 
2009;169(21):1952-60. 
Contact: Marie Richardson Pharmacy Dept, OLOL Drogheda 
mariee.richardson@hse.ie
Authors of this presentation have the  following to disclose concerning 
possible financial or personal relationship with commercial entities that may 
have a direct  or indirect interest in the subject matter  of the presentation :
Marie Richardson nothing to disclose; Claire O’Dwyer: nothing to disclose
Joanne Gaskin: nothing to disclose; Elaine Conyard: nothing to disclose; 
Kevin Murphy; nothing to disclose.
INTRODUCTION
METHODS
RESULTS 
CONCLUSIONS AND FUTURE RESEARCH
AIMS 
Acknowledgments: Dr Kevin Murphy UCC, Pharmacy Department OLOL 
Drogheda
A Study to Evaluate the Potential Contribution 
of Medication Use to Falls in  Elderly Patients 
Presenting to an Acute Hospital
Richardson M1, O’Dwyer C1, Gaskin J1, Conyard E1, Murphy K2
Pharmacy Department Our Lady of Lourdes Hospital Drogheda1, 
School of Pharmacy, University College Cork, Ireland2
Aim:
Examine the role of medicines in acute falls in patients ≥65 years presenting at
Our Lady of Lourdes Hospital Drogheda (OLOL)
Objectives:
1: Examine Polypharmacy
2: Examine Falls Risk Increasing Drugs (FRIDs)
3: Compare Medicine Profile of Long Term Care Facility (LTCF) v Community Patients
4: Examine the Role of Clinical Pharmacist in reducing Falls Risk
Falls in elderly patients is a growing burden on healthcare resources worldwide accounting
for 10-15% of acute hospital presentations in patients ≥ 60 years old. As this is the fastest
growing age group this will be a more significant issue in the future (6,10).
The cost of falls treatment in Ireland is anticipated to double in next 25 years. In 2020 the
projected costs are anticipated to be in the range of €922 to €1077 million, while in 2030
the projected costs are expected to be in the range of €1587 to €2043 million (4).
Polypharmacy is a modifiable extrinsic risk factor for falls in elderly patients. Medicine
choice is also a modifiable risk factor for falls in the elderly, with specific medicines
classified as Falls Risk Increasing Drugs (FRIDs) (2-6).
This study will focus on the top five classes of medicines based on a meta-analysis study of
medication classes on falls in the elderly by Woolcott et al (11).
Clinical Pharmacists have a significant role to play in managing and reducing the risk of
falls in this patient group by managing polypharmacy and FRID prescribing as part of
multidisciplinary management of elderly patients (1,7-9).
Ethics approval was sought and granted from the HSE North-East Area Research
Ethics Committee.
The acute admissions records in the Emergency Department (ED) and the Acute Medical
Assessment Unit (AMAU) of OLOL were searched on a daily basis for patients ≥65 years
who had presented due to an acute fall or due to injuries sustained as a result of an acute
fall based on the inclusion and exclusion criteria as detailed in Table 1. Data was collected
for a 6 week period from June 1st to July 13th 2018.
Table 1: Inclusion and Exclusion Criteria
Informed consent for participation in the study was sought from the patient or next of kin
as deemed appropriate by a Clinical Pharmacist. If consent was granted, the Clinical
Pharmacist provided routine clinical pharmacy service to the patient which involved:
medicines reconciliation, review of renal and hepatic function, review of observations,
review of prescribed medicines for: polypharmacy, duplication of therapy, interactions &
patient specific medicine appropriateness.
The Clinical Pharmacist made recommendations to the patient’s medical team regarding
their medicines with a view to reducing their risk of future falls. A data collection sheet
was completed for each patient. All medical records were reviewed by a Clinical
Pharmacist between July 16th and 20th 2018 to determine the extent of implementation of
their recommendations.
Data collected was logged in a master spreadsheet, anonymised & analysed using
quantitative statistical analysis. All date was stored securely.
94 patients were identified as presenting due to a fall and were approached for consent. Informed
consent was obtained for 53 patients, 41 were excluded or did not give consent.
➢46.3% of those excluded had dementia or confusion when approached for informed consent.
Next of kin were not available to discuss the study or to give informed consent on their behalf.
➢22% of those excluded were discharged before they could be approached for consent to
participate in the study.
➢69.8% of patients recruited were admitted to wards without a clinical pharmacy service, leading
to increased time required. It also proved difficult for the Clinical Pharmacist to discuss
recommendations with medical teams and to have recommendations enacted.
Polypharmacy:
➢77% of those recruited were on ≥5 medicines on admission
➢32 % of those recruited were on ≥10 medicines on admission.
➢100% of patients prescribed benzodiazepines, sedatives and antipsychotic medicines were on
≥5 medicines on admission .
➢94% of those on antidepressants were on ≥5 medicines on admission.
➢76% of those prescribed antihypertensives were on ≥5 medicines on admission.
On review 83% of patients were on ≥5 medicines. The increase in the number of medicines was
predominantly due to analgesics and laxatives. 47.2 % had in increase in the number of medicines
prescribed, 20.8% of patients had a reduction in the number of medicines prescribed, while 32.1%
were unchanged. It would have been desirable to review patients at a later point when analgesia
and laxatives and acute medicines had ceased.
Classes of Medicines:
Table 2: Medicine Classes per Patient on Admission
➢94.3% of patients on ≥ 1 FRID on admission
➢Total of 83 antihypertensive agents prescribed to 42 patients on admission
➢ On review, there was a reduction of 15 antihypertensive agents prescribed with 10 diuretics
ceased.
➢ One sedative was stopped and two benzodiazepines were stopped while a further three patients
had their benzodiazepine dose reduced with a view to cessation, however the process had not
been completed at the time of review. Cessation of sedatives and benzodiazepines has to be
completed slowly in a stepwise manner to minimise patient distress.
There was no reduction in the prescribing of antipsychotics and an increase of two patients
prescribed antidepressants.
LTCF v Community Patients:
Only one LTCF patient was recruited therefore this objective could not be examined.
Role of the Clinical Pharmacist:
Clinical Pharmacists made recommendations for changes to patients medicines aimed at reducing
the risk of future falls. The recommendations were reviewed by the patients medical team and
discussed with the Clinical Pharmacist if necessary. 41.7% of recommendations were fully
actioned. Based on the Woolcott et al meta-analysis the Falls Odds Risk Ratios (FROR) was
calculated on admission and on review. FROR was reduced for benzodiazepines, diuretics, ACE
inhibitors and Angiotensin Receptor Blockers. FROR was increased for antidepressants and
unchanged for other classes of medicines.
The reduction in the FROR was not statistically significant (p=0.22).
Male Female Total %
Antihypertensives 22 20 42 79.2%
Antidepressants 5 11 16 30.2%
Benzodiazepines 3 4 7 13.2%
Antipsychotics 0 1 1 1.9%
Neuroleptics 0 0 0 0
Sedatives 4 2 6 11.3%
Inclusion Criteria ≥65 years , acute fall presentation
Exclusion Criteria: ≤65 years , non-acute fall presentation, fall as an inpatient, 
not on any regular prescribed medicine
Clinical Pharmacists have a key role to play in identifying polypharmacy and FRIDs in elderly patients at risk of falls. There is a significant role for them as part of the multidisciplinary team in
medicines management and reducing the risk of future falls in elderly patients therefore expansion of clinical pharmacy services is important in medicines management and reducing future falls risk.
There is scope for significant future research in this area including: longer follow-up period for patients after Clinical Pharmacist review and review after discharge from hospital to determine if
suggested changed to medicines have been implemented and sustained. Clinical Pharmacists can have input in development of education programmes for prescribers to highlight FRIDs and
polypharmacy in elderly patients at risk of falls. There is Clinical Pharmacist involvement in development of a Falls Prevention Policy in the North-Eastern HSE area as a result of this research.
